BESREMi Pen
Active substance: ropeginterferon alfa-2b
INJECTION, SOLUTION · ROPEGINTERFERON ALFA-2B 500 ug/.5mL
United StatesActive
Marketing holder: PharmaEssentia USA
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ROPEGINTERFERON ALFA-2B · 500 ug/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ee9-7a75-a790-ad529013ff4a,01a1208c-2eea-77cc-9038-35d723b3b0d8;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73536-511
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 73536-511 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73536-511 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73536-511 · Verified 2026-10-09 · open in source